Phase 1/2 Combination Studies: Best Practices When Moving From Escalation to Expansion
In this article, we discuss best practices for combination Phase 1/2 studies and how to maintain momentum moving from escalation to expansion.
CATEGORIES
Phase 1/2 Combination Studies: Best Practices When Moving From Escalation to Expansion
May 17, 2021
In this article, we discuss best practices for combination Phase...
Precision for Medicine: Powered by Our People
April 05, 2021
Precision for Medicine as a global CRO, invests in our...
Next Generation Immune Monitoring in Immuno-oncology Trials
March 17, 2021
A critical component of I-O studies, immune monitoring is essential...
Taking a Holistic Approach to Sample Management and Sample Processing for Your Clinical Trial
February 04, 2021
Patient samples have always been critical assets for clinical trial...
Why Immuno-Oncology Slowed and How to Reignite It
February 04, 2021
Cancer immunotherapy advances continue and enthusiasm for these approaches remains...
Choosing the Right Partner: Special Sample Needs For In Vitro Diagnostics
February 04, 2021
Is a sample just a sample? You’d be surprised. Karen...
